Iterum Therapeutics PLC expected to post a loss of 5  cents a share - Earnings Preview

Iterum Therapeutics

10/05/2022 14:05

* Iterum Therapeutics PLC  ITRM.OQ   ITRM.O  is expected
to show
no change in quarterly revenue when it reports  results on May
12 (estimated). 
    * ​Refinitiv's mean analyst estimate for Iterum Therapeutics
PLC
is for a loss of 5 cents per share. For the same quarter last
year, the company reported a loss of 81 cents per share.
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated May 10 at 13:05 GMT.  All
figures in US dollars  unless otherwise stated